Three patients diagnosed with advanced malignancies [malignant solitary fibrous tumor, colorectal cancer (CRC), and leiomyosarcoma] were treated with sunitinib in context of a clinical trial at a dose of 37.5 to 50 mg/d for at least 4 weeks. Tumors of these patients were biopsied and in parallel plasma samples were collected. The use of these samples was in accordance with the local ethical guidelines at VU University Medical Center. For the determination of sunitinib in tissue (tumor or skin), an amount of about 10 mg of snap frozen tissue was cut, put into a vial and weighed. A total of 200 μL of water was added, the sample was snap-frozen and freeze-dried overnight. For extraction, 200 μL of ice-cold 83% acetonitrile (ACN) was added and left on ice for 1 hour. After centrifugation, 50 μL of super-natant was transferred for subsequent liquid chromatography—tandem mass spectrometry (LC/MS-MS) analysis as reported previously for plasma and cell pellet homogenates (13 ). The data are expressed in micromole to allow comparison of tissue concentrations with the IC50 values in cell culture and are based on the conversion of 1 g tissue to 1 mL liquid (14 (link)).
Sunitinib Pharmacokinetics in Tumor Tissue
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Amsterdam UMC Location VUmc
Protocol cited in 4 other protocols
Variable analysis
- Sunitinib treatment (40 mg/kg/d)
- Tumor growth (in mice)
- Sunitinib concentration in tumor tissue (in patients)
- Female BALB/c mice
- Renca RCC tumor cells (5 × 10^5 cells)
- Tumor biopsy and plasma collection (in patients)
- Positive control: Not mentioned
- Negative control: Not mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!